A
$ Value
$0
Shares
157
Price
$0
Filed
Oct 3
Insider
Name
Lassiter Wright III
Title
—
CIK
0001805909
Roles
Director
Transaction Details
Transaction Date
2025-10-01
Code
A
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
679
Footnotes
Phantom stock units resulting from elective deferrals of a director's cash compensation pursuant to the Quest Diagnostics Incorporated Amended and Restated Deferred Compensation Plan for Directors and become payable in cash upon the reporting person's termination of service as a director. | Total number of phantom stock units accrued as of the transaction date in the reporting person's deferred compensation account includes phantom stock units credited as a result of dividend reinvestment transactions exempt from reporting pursuant to Rule 16a-11.
Filing Info
Lassiter Wright III's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-03-26 | FTV | L | $257 |
| 2026-01-28 | DGX | L | $1K |
| 2025-12-26 | FTV | L | $257 |
| 2025-10-01 | DGX | A | $0 |
| 2025-07-21 | DGX | L | $1K |
| 2025-07-01 | DGX | A | $0 |
| 2025-06-02 | FTV | A | $0 |
| 2025-06-02 | FTV | A | $115K |
| 2025-06-02 | FTV | A | $0 |
| 2025-05-15 | DGX | A | $0 |
Other Insiders at DGX (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| CARTER ROBERT B | — | — | 2026-01-28 |
|
PREVOZNIK MICHAEL E
SVP & General Counsel
|
— | $228K | 2026-02-19 |
| WENTWORTH TIMOTHY C | — | — | 2026-04-01 |
|
Plewman Patrick
SVP for Diagnostic Services
|
— | $1.4M | 2026-02-19 |
| Gregg Vicky B | — | — | 2026-01-28 |
|
Doherty Catherine T.
EVP, Regional Businesses
|
— | $5.7M | 2026-02-19 |
|
Davis J. E.
CEO and President
|
— | — | 2026-02-18 |
|
SAMAD SAM
Executive Vice President & CFO
|
— | — | 2026-02-18 |
|
Deppe Michael J
SVP, Corp. Controller & CAO
|
— | — | 2026-02-18 |
| Lassiter Wright III | — | — | 2026-01-28 |
|
KUPPUSAMY KARTHIK
SVP, Clinical Solutions
|
— | — | 2026-02-18 |
|
DELANEY MARK E
SVP & Chief Commercial Officer
|
— | — | 2026-02-18 |